Adagio Closes $42.5M Financing To Develop Ablation Technologies

 
• By Reed Miller

The series E financing will support the ongoing US trial of Adagio’s iCLAS cardiac cryoablation system and development of Adagio's pulsed field cryoablation technology while the company continues to commercialize iCLAS outside the US.

Venture Capital Concept on the Mechanism of Metal Gears.
• Source: shutterstock.com

More from Financing

More from Business